Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Cholesterol

Study protocol for a double-blind randomised controlled trial investigating the impact of 12 weeks supplementation with a Fucus vesiculosus extract on cholesterol levels in adults with elevated fasting LDL cholesterol who are overweight or have obesity

M. Murray; A. L. Dordevic; K. H. M. Cox; A. Scholey; L. Ryan; M. P. Bonham Study protocol for a double-blind randomised controlled trial investigating the impact of 12 weeks supplementation with a Fucus vesiculosus extract on cholesterol levels in adults with elevated fasting LDL cholesterol who are overweight or have obesity BMJ Open
Cholesterol

Nutritionally Derived Metabolic Cues Typical of the Obese Microenvironment Increase Cholesterol Efflux Capacity of Adipose Tissue Macrophages

M. E. O'Reilly; S. Kajani; J. C. Ralston; Y. M. Lenighan; H. M. Roche; F. C. McGillicuddy Nutritionally Derived Metabolic Cues Typical of the Obese Microenvironment Increase Cholesterol Efflux Capacity of Adipose Tissue Macrophages Mol Nutr Food Res
Cholesterol

Insulin resistance determines a differential response to changes in dietary fat modification on metabolic syndrome risk factors: the LIPGENE study

E. M. Yubero-Serrano; J. Delgado-Lista; A. C. Tierney; P. Perez-Martinez; A. Garcia-Rios; J. F. Alcala-Diaz; J. P. Castaño; F. J. Tinahones; C. A. Drevon; C. Defoort; E. E. Blaak; A. Dembinska-Kieć; U. Risérus; J. A. Lovegrove; F. Perez-Jimenez; H. M. Roc Insulin resistance determines a differential response to changes in dietary fat modification on metabolic syndrome risk factors: the LIPGENE study Am J Clin Nutr
Cholesterol Insulin Resistance & Diabetes Metabolic Syndrome

Dietary fat, abdominal obesity and smoking modulate the relationship between plasma complement component 3 concentrations and metabolic syndrome risk

C. M. Phillips; E. Kesse-Guyot; N. Ahluwalia; R. McManus; S. Hercberg; D. Lairon; R. Planells; H. M. Roche Dietary fat, abdominal obesity and smoking modulate the relationship between plasma complement component 3 concentrations and metabolic syndrome risk Atherosclerosis
Cholesterol Insulin Resistance & Diabetes Metabolic Syndrome

Influence of endothelial dysfunction on telomere length in subjects with metabolic syndrome: LIPGENE study

L. González-Guardia; E. M. Yubero-Serrano; O. Rangel-Zuñiga; C. Marin; A. Camargo; P. Pérez-Martínez; J. Delgado-Lista; F. Gómez-Delgado; A. Garcia-Rios; F. J. Tinahones; H. M. Roche; F. Pérez-Jiménez; J. López-Miranda Influence of endothelial dysfunction on telomere length in subjects with metabolic syndrome: LIPGENE study Age
Cholesterol Genetics Metabolic Syndrome

Blueberry anthocyanin intake attenuates the postprandial cardiometabolic effect of an energy-dense food challenge: Results from a double blind, randomized controlled trial in metabolic syndrome participants

P. J. Curtis; L. Berends; V. van der Velpen; A. Jennings; L. Haag; P. Chandra; C. D. Kay; E. B. Rimm; A. Cassidy Blueberry anthocyanin intake attenuates the postprandial cardiometabolic effect of an energy-dense food challenge: Results from a double blind, randomized controlled trial in metabolic syndrome participants Clinical Nutrition
Cholesterol Metabolic Syndrome

Endoplasmic reticulum stress in adipose tissue determines postprandial lipoprotein metabolism in metabolic syndrome patients

A. Camargo; M. E. Meneses; O. A. Rangel-Zuñiga; P. Perez-Martinez; C. Marin; J. Delgado-Lista; J. A. Paniagua; F. J. Tinahones; H. Roche; M. M. Malagon; F. Perez-Jimenez; J. Lopez-Miranda Endoplasmic reticulum stress in adipose tissue determines postprandial lipoprotein metabolism in metabolic syndrome patients Molecular Nutrition and Food Research
Cholesterol Metabolic Syndrome

Pioglitazone protects HDL(2&3) against oxidation in overweight and obese men

J. McEneny; P. A. McPherson; A. McGinty; S. S. Hull; D. R. McCance; I. S. Young Pioglitazone protects HDL(2&3) against oxidation in overweight and obese men Ann Clin Biochem
Cholesterol

Limited Impact of Fetal Sex and Maternal Body Mass Index on Fetal and Maternal Insulin Resistance and Lipid Metabolism: Findings from the PEARs Study

A. R. Rafferty; A. A. Geraghty; M. A. Kennelly; E. C. O'Brien; R. M. Reji; J. Mehegan; R. Segurado; T. Smith; O. Maguire; M. Cronin; F. M. McAuliffe Limited Impact of Fetal Sex and Maternal Body Mass Index on Fetal and Maternal Insulin Resistance and Lipid Metabolism: Findings from the PEARs Study Reprod Sci
Cholesterol Insulin Resistance & Diabetes

Maternal obesity and dyslipidemia associated with gestational diabetes mellitus (GDM)

E. G. O'Malley; C. M. E. Reynolds; A. Killalea; R. O'Kelly; S. R. Sheehan; M. J. Turner Maternal obesity and dyslipidemia associated with gestational diabetes mellitus (GDM) Eur J Obstet Gynecol Reprod Biol
Cholesterol Insulin Resistance & Diabetes

Older posts

Newer posts

← Previous Page1 Page2 Page3 Page4 Page5 Next →

Search for:

Recent Posts

Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update
ECO2023 Teaching Workshops – Registration Open!

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Menu

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2024 ASOI